Congenital hearing loss is hearing loss that is present at birth. It affects roughly 1.7 out of every 1,000 newborns in the United States, which translates to more than 6,000 babies identified each year. The loss can range from mild to profound and may affect one or both ears. Some cases are caught within days through routine hospital screening, while others aren’t identified until a child misses early speech milestones.
Sensorineural, Conductive, and Mixed Types
Congenital hearing loss falls into three categories based on where the problem occurs in the ear.
Sensorineural hearing loss is the most common type in newborns and the primary cause of permanent hearing loss in children. It happens when the tiny hair cells inside the inner ear (cochlea) are damaged or when the nerve that carries sound signals to the brain doesn’t work properly. Because the damage is in the inner ear or nerve pathway, this type is usually permanent.
Conductive hearing loss results from a physical problem in the outer or middle ear that blocks sound from reaching the inner ear. In newborns, this can stem from structural abnormalities like a narrowed ear canal or malformed bones in the middle ear. Conductive loss is sometimes treatable with surgery.
Mixed hearing loss involves both a sensorineural and a conductive component at the same time.
Genetic Causes
Genetics account for the majority of congenital hearing loss cases. The most common genetic cause is a change in a gene called GJB2, which provides instructions for building a protein that helps cells in the inner ear communicate. When both copies of this gene carry a mutation, the result is typically severe-to-profound hearing loss that is present at birth and does not get worse over time. In people of northern European descent, 2 to 4 percent carry one copy of the most common GJB2 mutation. Parents who carry one faulty copy usually hear normally themselves, but if both parents are carriers, each pregnancy has a one-in-four chance of producing a child with hearing loss.
More than 70 genes have been linked to nonsyndromic hearing loss (meaning hearing loss is the only symptom). But in some cases, hearing loss is part of a broader syndrome that affects other parts of the body:
- Usher syndrome is the most common autosomal recessive form. It combines hearing loss with progressive vision loss from retinitis pigmentosa. The most severe subtype causes profound deafness from birth along with balance problems, while milder forms cause less hearing loss and vision changes that appear around puberty.
- Waardenburg syndrome is the most common autosomal dominant form, accounting for about 3 percent of childhood hearing loss. Children may have distinctive features like differently colored eyes, a white streak of hair near the forehead, and widely spaced inner eye corners.
- Alport syndrome affects the kidneys and inner ear together, causing progressive hearing loss alongside kidney disease. It primarily affects males.
Infections and Other Prenatal Causes
Not all congenital hearing loss is genetic. Infections passed from mother to baby during pregnancy are a major non-genetic cause. These are sometimes grouped under the acronym TORCH: toxoplasmosis, rubella, cytomegalovirus (CMV), and herpes simplex, along with syphilis and other pathogens.
CMV is the single most common congenital infection and the leading non-genetic cause of congenital hearing loss in developed countries. It spreads through bodily fluids and can cross the placenta during pregnancy. Babies born with CMV may also have low birth weight, jaundice, and vision problems, though some show no symptoms at birth and develop hearing loss later. Maternal CMV infection occurs in roughly 2 to 10 out of every 1,000 births.
Rubella was once a major cause of congenital deafness, but widespread vaccination has made it rare in countries with strong immunization programs. When it does occur, congenital rubella syndrome can cause hearing loss alongside heart defects, cataracts, and low birth weight. Toxoplasmosis, which pregnant women can contract from undercooked meat or contact with cat feces, can also lead to hearing loss in the baby, along with brain and eye damage.
Beyond infections, maternal factors like certain medications taken during pregnancy, preeclampsia, and complications during delivery can also contribute.
How Newborn Hearing Screening Works
Most hospitals in the United States screen newborns for hearing loss before discharge, typically within the first day or two of life. Two types of painless, quick tests are used.
The otoacoustic emissions (OAE) test places a tiny earpiece in the baby’s ear canal and plays soft sounds. A healthy inner ear produces faint echoes in response, which the device picks up. If no echoes are detected, it suggests the hair cells in the inner ear may not be functioning normally.
The auditory brainstem response (ABR) test uses small sensors placed on the baby’s head to measure electrical activity in the hearing nerve and brainstem while sounds are played. This test goes a step further than OAE by checking whether sound signals are reaching the brain, not just the inner ear. It can detect problems along the entire pathway from the ear to the brainstem.
A baby who doesn’t pass an initial screening isn’t necessarily deaf. Fluid in the ear canal, background noise, or a fussy baby can all affect results. That’s why a failed screening leads to follow-up testing, not an immediate diagnosis.
The 1-3-6 Timeline
The CDC promotes a set of benchmarks known as the 1-3-6 guidelines for catching and addressing hearing loss early. The goals are straightforward: screen by 1 month of age, confirm a diagnosis by 3 months, and enroll in early intervention services by 6 months.
This timeline exists because of strong evidence that early action makes a real difference. Children with hearing loss are at risk for delays in speech, vocabulary, grammar, reading, and social development compared to their hearing peers. But research consistently shows that children identified early, fitted with hearing devices by 3 months, and enrolled in intervention by 6 months develop language skills significantly closer to those of children with normal hearing. Children identified after 6 months tend to have more pronounced delays, particularly in the building blocks of language like sound recognition, sentence structure, and vocabulary size.
Hearing Aids and Cochlear Implants
The first step in managing congenital hearing loss is usually a hearing aid, which amplifies sound and sends it through the ear. For mild to moderate loss, hearing aids are often enough to support speech and language development when fitted early. Babies can be fitted with hearing aids within the first few months of life.
For severe to profound hearing loss where hearing aids don’t provide enough benefit, cochlear implants are the next option. Unlike hearing aids, which make sounds louder, a cochlear implant bypasses the damaged hair cells entirely and stimulates the hearing nerve directly with electrical signals. The brain learns to interpret these signals as sound. Children can receive a cochlear implant as young as 9 months of age. The FDA has approved implants for children 9 months and older with severe-to-profound loss in both ears, and for children 5 and older with profound loss in just one ear.
Cochlear implants require surgery followed by weeks of programming and adjustment, then ongoing speech therapy to help the child’s brain learn to process the new signals. The earlier implantation happens, the better the outcomes tend to be for spoken language development, because the brain’s ability to organize itself around sound input is strongest in the first few years of life.
Some families choose sign language as a primary or supplementary communication method, and many children with hearing loss thrive using a combination of sign language and spoken language. The choice depends on the degree of hearing loss, family preferences, and the resources available.